JOURNAL OF GLAUCOMA

Scope & Guideline

Pioneering advancements in glaucoma management and treatment.

Introduction

Welcome to your portal for understanding JOURNAL OF GLAUCOMA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1057-0829
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1992 to 2024
AbbreviationJ GLAUCOMA / J. Glaucoma
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The Journal of Glaucoma focuses on advancing the understanding, diagnosis, and management of glaucoma, a leading cause of irreversible vision loss worldwide. The journal provides a platform for research that spans clinical, epidemiological, and technological advancements in the field.
  1. Clinical Management and Surgical Techniques:
    Research related to innovative surgical techniques and clinical management strategies for various types of glaucoma, including advanced and pediatric glaucoma.
  2. Diagnostic Methods and Technologies:
    Studies exploring the efficacy of various diagnostic methods, including optical coherence tomography, tonometry, and machine learning applications in glaucoma detection and monitoring.
  3. Epidemiology and Risk Factors:
    Investigations into the epidemiology of glaucoma, including prevalence studies, risk factors, and health disparities affecting different populations.
  4. Pharmacological Treatments and Therapies:
    Research on the efficacy and safety of current pharmacological treatments for glaucoma, as well as novel therapeutic approaches and drug delivery systems.
  5. Vision Function and Quality of Life:
    Studies assessing the impact of glaucoma on vision-related quality of life, including psychological factors and patient adherence to treatment.
  6. Innovations in Screening and Telemedicine:
    Research on new screening methodologies and the use of telemedicine in glaucoma detection and management, particularly in underserved populations.
The Journal of Glaucoma has identified several trending and emerging themes that reflect the current interests and advancements in glaucoma research. These themes indicate a shift towards technology integration, patient-centered approaches, and novel therapeutic strategies.
  1. Artificial Intelligence and Machine Learning:
    There is an increasing focus on the application of artificial intelligence and machine learning in glaucoma diagnosis and management, showing potential for improving detection and treatment outcomes.
  2. Minimally Invasive Glaucoma Surgery (MIGS):
    Research on minimally invasive surgical techniques is gaining momentum, reflecting a shift towards less traumatic options for patients with glaucoma.
  3. Telemedicine and Remote Monitoring:
    Emerging studies highlight the importance of telemedicine and remote monitoring, particularly in response to the COVID-19 pandemic, to enhance access to care for glaucoma patients.
  4. Patient-Centered Outcomes:
    An increasing number of studies are focusing on patient-reported outcomes and quality of life measures, emphasizing the need for patient-centered approaches in glaucoma management.
  5. Genetic and Molecular Research:
    There is growing interest in the genetic underpinnings of glaucoma, with studies exploring genetic risk factors and their implications for personalized treatment strategies.
  6. Integration of Digital Health Technologies:
    Research is trending towards the integration of digital health technologies, such as mobile health applications, to improve patient engagement and adherence to treatment.

Declining or Waning

While the Journal of Glaucoma continues to cover a wide range of topics, certain areas have seen a decline in focus over recent years. These waning scopes reflect shifts in research priorities and emerging trends in the field.
  1. Traditional Intraocular Pressure Measurement Techniques:
    There has been a noticeable decline in studies focusing solely on traditional intraocular pressure measurement techniques, as newer technologies and methodologies gain prominence.
  2. Surgical Techniques for Established Glaucoma:
    Research focusing on older surgical techniques without innovation has decreased, as there is a growing emphasis on novel approaches and minimally invasive procedures.
  3. Basic Science Studies without Clinical Application:
    The journal has seen a decline in basic science studies that do not have direct clinical implications or applications, as the focus shifts towards translational research.
  4. Single-Center Studies:
    There is a trend away from single-center studies towards multi-center collaborations and larger population-based studies, enhancing the generalizability of findings.

Similar Journals

Translational Vision Science & Technology

Transforming Insights into Impact in Vision Science
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 2164-2591Frequency: 6 issues/year

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

CURRENT OPINION IN OPHTHALMOLOGY

Advancing the Frontiers of Eye Care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8738Frequency: 6 issues/year

CURRENT OPINION IN OPHTHALMOLOGY is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the dynamic and evolving field of ophthalmology. With an impressive impact factor and a prestigious Q1 ranking in both Medicine (miscellaneous) and Ophthalmology for 2023, this journal is recognized for its authoritative reviews and critical summaries of contemporary research. Since its inception in 1990, the journal has served as an essential resource for ophthalmology professionals, providing insights into the latest advances in clinical practices, emerging technologies, and cutting-edge research. Although not open access, it is highly regarded for its rigorous peer-review process, ensuring the publication of high-quality, relevant findings. Researchers, clinicians, and students alike will find invaluable perspectives in its pages as they navigate the complexities of eye health and patient care.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Exploring New Horizons in Eye Health
Publisher: WILEYISSN: 1442-6404Frequency: 9 issues/year

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

EYE

Shaping the Future of Eye Health Through Innovative Scholarship
Publisher: SPRINGERNATUREISSN: 0950-222XFrequency: 12 issues/year

EYE is a prestigious peer-reviewed journal published by SpringerNature that serves as a cornerstone in the fields of Ophthalmology, Arts and Humanities, and Neuroscience. Since its inception in 1987, this influential journal has consistently maintained a Q1 Quartile ranking across multiple categories, showcasing its commitment to advancing knowledge and research in its disciplines. With a notable impact factor and a robust Scopus ranking—19th in Ophthalmology and 8th in Sensory Systems—EYE is vital for researchers, clinicians, and students alike, providing a platform for groundbreaking studies and critical reviews. While the journal operates under a subscription model, it ensures broad access to high-quality research, facilitating the dissemination of knowledge that shapes the future of eye health and sensory systems. With an address at Campus, 4 Crinan St, London N1 9XW, England, EYE continues to be a leading light in the understanding and advancement of visual health and sensory sciences.

BMC Ophthalmology

Fostering Global Collaboration in Vision Science
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Ophthalmology is a premier open access journal dedicated to advancing the field of ophthalmology through the publication of high-quality, peer-reviewed research. Published by BMC in the United Kingdom, this journal has been a vital resource since its inception in 2001 and continuously contributes to the global dialogue in vision science. With an impact factor reflecting its growing influence, BMC Ophthalmology is ranked among the top quartiles (Q2) in both general medicine and ophthalmology, emphasizing its significance in medical research. The journal encourages submissions that explore innovative diagnostics, treatment approaches, and understandings of various ocular diseases, thereby appealing to researchers, clinicians, and students alike. As an open access platform, it ensures that cutting-edge research is not only published but also readily accessible to a worldwide audience, promoting further study and collaboration in this essential area of medicine.

JAMA Ophthalmology

Pioneering Insights in Ophthalmology
Publisher: AMER MEDICAL ASSOCISSN: 2168-6165Frequency: 12 issues/year

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Open Ophthalmology Journal

Fostering discovery in the realm of ocular health.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-3641Frequency: 1 issue/year

The Open Ophthalmology Journal, published by Bentham Science Publishers Ltd, is a vital resource in the field of ophthalmology, dedicated to advancing knowledge through open-access research. With an ISSN of 1874-3641, it offers a platform for the dissemination of innovative studies from 2011 to 2024, focusing on the latest developments in eye care and vision science. Despite being categorized in the lower quartile (Q4) according to the 2023 rankings, and holding a position in the Scopus Ricks at 113 out of 137 in the ophthalmology domain, the journal serves as a valuable outlet for emerging scholars and seasoned researchers alike to share their findings. The journal's commitment to accessibility ensures that its content is available to a broad audience, promoting collaboration and knowledge exchange. Located in the Netherlands, The Open Ophthalmology Journal aspires to become a cornerstone for those passionate about understanding and improving ocular health through rigorous scientific inquiry.

LUTS-Lower Urinary Tract Symptoms

Unraveling the complexities of urinary health.
Publisher: WILEYISSN: 1757-5664Frequency: 6 issues/year

LUTS - Lower Urinary Tract Symptoms is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of urology and neurology with a special focus on lower urinary tract dysfunctions. Since its inception in 2010, the journal has established itself as an essential resource for researchers and practitioners, featuring cutting-edge research articles, reviews, and clinical studies that explore the complexities of lower urinary tract symptoms and their neurological implications. Housed in Japan, LUTS occupies an important niche in the academic landscape, currently ranked Q2 in Urology and Q3 in Neurology, and holding notable Scopus ranks within both fields. The journal serves as a platform for disseminating innovative ideas and fostering collaborative efforts among experts, making significant contributions to improve patient care and outcomes. With its commitment to high-quality scholarship, LUTS is an indispensable tool for those seeking to stay at the forefront of research in urology and neuroscience.

Ophthalmology Glaucoma

Transforming Glaucoma Management Through Innovation
Publisher: ELSEVIERISSN: 2589-4234Frequency: 6 issues/year

Ophthalmology Glaucoma is a premier academic journal dedicated to advancing the understanding and management of glaucoma, a leading cause of irreversible blindness worldwide. Published by Elsevier, this journal covers a broad spectrum of topics within the field of ophthalmology, providing a platform for groundbreaking research and clinical insights. With an impressive impact factor that places it in the Q1 category of ophthalmology journals, and a commendable Scopus ranking of 29 out of 137, Ophthalmology Glaucoma is recognized for its rigorous peer-review process and high-quality publications. Since its inception in 2018, the journal has focused on disseminating innovative findings and treatment modalities to enhance patient care and outcomes. Researchers, clinicians, and students are encouraged to explore the Open Access options available, promoting wider accessibility to critical scientific knowledge. By staying at the forefront of ophthalmic research, Ophthalmology Glaucoma plays an essential role in shaping practices and policies that improve eye health globally.

Journal of the Egyptian Ophthalmological Society

Exploring new horizons in eye health and research.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2090-0686Frequency: 4 issues/year

Journal of the Egyptian Ophthalmological Society is a premier academic journal dedicated to advancing the field of ophthalmology through high-quality peer-reviewed research. Published by Wolters Kluwer Medknow Publications, this journal plays a critical role in disseminating vital findings and innovations in eye care, fostering knowledge exchange among researchers, practitioners, and educators worldwide. Since its transformation to Open Access in 2014, it has significantly enhanced the accessibility of eye health information, thereby broadening its impact on the global scientific community. With an ISSN of 2090-0686 and an E-ISSN of 2314-6648, the journal aims to tackle contemporary issues in ophthalmology, including clinical practices, public health, and technological advancements in eye care. The journal's commitment to excellence ensures that it remains a vital resource for those looking to contribute meaningfully to this dynamic and crucial field.